SLDE director exercises options, sells 10,000 shares

Slide Insurance Holdings director Stephen L. Rohde reported an exercise-and-sale transaction involving 10,000 shares of Common Stock.

Rhea-AI Filing Summary

Slide Insurance Holdings director Stephen L. Rohde reported an exercise-and-sale transaction involving 10,000 shares of Common Stock. On March 13, 2026, he exercised stock options to acquire 10,000 shares of Common Stock at an exercise price of $0.0018 per share. The stock options were fully vested and exercisable. That same day, he sold 10,000 shares of Common Stock in the open market at a price of $17.78 per share, resulting in no directly held Common Stock after the sale. Following the option exercise, he continued to hold 7,500 stock options directly.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($178K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider ROHDE STEPHEN L

Role Director

Sold 10,000 shs ($178K)

Approx. gross sale proceeds $178K

Approx. exercise cost $18.00

Approx. pre-tax spread $178K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	10,000	$0.00	$0.00
Exercise	Common Stock	10,000	$0.0018	$18.00
Sale	Common Stock	10,000	$17.78	$178K

Holdings After Transaction: Stock Option (Right to Buy) — 7,500 contracts (Direct); Common Stock — 0 shares (Direct)

Footnotes (1)

1. F1. These stock options are fully vested and exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SLDE director Stephen L. Rohde report?

Stephen L. Rohde reported exercising options for 10,000 SLDE shares and selling 10,000 Common Stock shares. The transactions occurred on March 13, 2026, and were disclosed as an exercise-and-sale sequence in a Form 4 insider filing.

How many Slide Insurance (SLDE) shares did Stephen L. Rohde sell?

Stephen L. Rohde sold 10,000 shares of Slide Insurance Common Stock. The sale took place on March 13, 2026, immediately after exercising stock options that delivered the same 10,000 shares into his direct ownership before disposition.

At what prices did the SLDE option exercise and share sale occur?

The stock options were exercised at an exercise price of $0.0018 per share, while the resulting 10,000 Common Stock shares were sold at $17.78 per share. Both the exercise and sale occurred on March 13, 2026, according to the Form 4.

What are Stephen L. Rohde’s Slide Insurance holdings after this Form 4?

After these transactions, Stephen L. Rohde reported holding no shares of Slide Insurance Common Stock directly. He reported 7,500 stock options remaining following the exercise of 10,000 options from a previously larger fully vested and exercisable grant.

What type of transaction is indicated by code M in the SLDE Form 4?

Transaction code M in this SLDE Form 4 indicates an exercise or conversion of a derivative security. Here, it reflects the exercise of stock options to acquire 10,000 shares of Common Stock before those same shares were sold in an open-market transaction.

Was the Slide Insurance (SLDE) option grant fully vested at exercise?

Yes. The footnote states the stock options were fully vested and exercisable. On March 13, 2026, Stephen L. Rohde exercised 10,000 options from this vested grant, then sold the resulting 10,000 Common Stock shares in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROHDE STEPHEN L

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		M		10,000	A	$0.0018	10,000	D
Common Stock	03/13/2026		S		10,000	D	$17.78	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.0018	03/13/2026		M			10,000	(1)	10/07/2031	Common Stock	10,000	$0	7,500	D

Explanation of Responses:

1. These stock options are fully vested and exercisable.

	/s/ Stephen Rohde	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.